EPZM logo

Epizyme (EPZM) Cash From Operations

Annual CFO

-$226.85 M
-$20.52 M-9.94%

December 31, 2021

Summary

Performance

1-Year Change

-9.94%

3-Year Change

-86.56%

5-Year Change

-88.36%

15-Year Change

-88.36%

EPZM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$44.15 M
EPZM annual cash flow from operations is currently -613.78% below its historical high of $44.15 million

3-Year Low

-$226.85 M
EPZM annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
EPZM previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
EPZM next annual earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

Annual CFI

$125.48 M
EPZM annual cash flow from investing activities is $125.48 million

Annual CFF

$31.49 M
EPZM annual cash flow from financing activities is $31.49 million

Annual FCF

-$227.34 M
EPZM annual free cash flow is -$227.34 million

Annual CAPEX

$486.00 K
EPZM annual capital expenditures is $486.00 thousand

Quarterly CFO

-$54.81 M
+$4.38 M+7.40%

June 30, 2022

Summary

Performance

3-Month Change

+7.4%

1-Year Change

+3.29%

3-Year Change

-30.83%

5-Year Change

-205.97%

EPZM Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$58.65 M
EPZM quarterly cash flow from operations is currently -193.45% below its historical high of $58.65 million

3-Year Low

-$59.19 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

Quarterly CFI

$48.71 M
EPZM quarterly cash flow from investing activities is $48.71 million

Quarterly CFF

-$257.00 K
EPZM quarterly cash flow from financing activities is -$257.00 thousand

Quarterly FCF

-$54.81 M
EPZM quarterly free cash flow is -$54.81 million

Quarterly CAPEX

$0.00
EPZM quarterly capital expenditures is $0.00

TTM CFO

-$208.60 M
+$1.86 M+0.89%

June 30, 2022

Summary

Performance

3-Month Change

+0.89%

1-Year Change

+8.46%

3-Year Change

-41.75%

5-Year Change

-41.75%

EPZM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$56.76 M
EPZM TTM cash flow from operations is currently -467.53% below its historical high of $56.76 million

3-Year Low

-$226.85 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

TTM CFI

$89.34 M
EPZM TTM cash flow from investing activities is $89.34 million

TTM CFF

$110.16 M
EPZM TTM cash flow from financing activities is $110.16 million

TTM FCF

-$208.88 M
EPZM TTM free cash flow is -$208.88 million

TTM CAPEX

$275.00 K
EPZM TTM capital expenditures is $275.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

EPZM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.9%+3.3%+8.5%
3 y3 years-86.6%-30.8%-41.8%
5 y5 years-88.4%-206.0%-41.8%

EPZM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+5.5%+8.0%at high+8.7%
5 y5-year+54.1%at low+54.5%+37.9%+41.7%+9.3%
alltimeall time-613.8%at low-193.5%+37.9%-467.5%+9.3%

Epizyme Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2022
-
-$54.81 M(-7.4%)
-$208.60 M(-0.9%)
Mar 2022
-
-$59.19 M(+13.9%)
-$210.47 M(-7.2%)
Dec 2021
-$226.85 M(+9.9%)
-$51.97 M(+21.9%)
-$226.85 M(-0.5%)
Sep 2021
-
-$42.64 M(-24.8%)
-$228.00 M(+0.1%)
Jun 2021
-
-$56.67 M(-25.0%)
-$227.89 M(+1.9%)
Mar 2021
-
-$75.58 M(+42.3%)
-$223.64 M(+8.4%)
Dec 2020
-$206.34 M(+40.2%)
-$53.12 M(+24.9%)
-$206.34 M(+9.3%)
Sep 2020
-
-$42.52 M(-18.9%)
-$188.71 M(+2.3%)
Jun 2020
-
-$52.43 M(-10.0%)
-$184.41 M(+6.1%)
Mar 2020
-
-$58.27 M(+64.2%)
-$173.87 M(+18.1%)
Dec 2019
-$147.17 M(+21.0%)
-$35.48 M(-7.2%)
-$147.17 M(+9.6%)
Sep 2019
-
-$38.23 M(-8.7%)
-$134.24 M(+1.8%)
Jun 2019
-
-$41.89 M(+32.7%)
-$131.82 M(+7.3%)
Mar 2019
-
-$31.56 M(+39.9%)
-$122.82 M(+1.0%)
Dec 2018
-$121.60 M(+1.0%)
-$22.55 M(-37.0%)
-$121.60 M(-6.1%)
Sep 2018
-
-$35.82 M(+8.9%)
-$129.44 M(-2.3%)
Jun 2018
-
-$32.89 M(+8.4%)
-$132.51 M(+12.7%)
Mar 2018
-
-$30.34 M(-0.2%)
-$117.54 M(-2.4%)
Dec 2017
-$120.43 M
-$30.39 M(-21.9%)
-$120.43 M(+8.5%)
Sep 2017
-
-$38.89 M(+117.1%)
-$111.02 M(+14.0%)
Jun 2017
-
-$17.91 M(-46.1%)
-$97.37 M(-6.5%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$33.23 M(+58.4%)
-$104.16 M(+8.1%)
Dec 2016
-$96.37 M(+32.2%)
-$20.98 M(-16.9%)
-$96.37 M(-0.7%)
Sep 2016
-
-$25.25 M(+2.2%)
-$97.00 M(+22.3%)
Jun 2016
-
-$24.70 M(-2.9%)
-$79.29 M(+4.8%)
Mar 2016
-
-$25.45 M(+17.8%)
-$75.66 M(+3.8%)
Dec 2015
-$72.92 M(+106.2%)
-$21.61 M(+187.1%)
-$72.92 M(+0.9%)
Sep 2015
-
-$7.53 M(-64.3%)
-$72.28 M(-13.8%)
Jun 2015
-
-$21.08 M(-7.2%)
-$83.82 M(+19.8%)
Mar 2015
-
-$22.71 M(+8.3%)
-$69.95 M(+97.8%)
Dec 2014
-$35.36 M(-34.2%)
-$20.96 M(+10.0%)
-$35.36 M(+17.5%)
Sep 2014
-
-$19.06 M(+164.4%)
-$30.10 M(+55.3%)
Jun 2014
-
-$7.21 M(-160.7%)
-$19.38 M(-32.8%)
Mar 2014
-
$11.88 M(-175.6%)
-$28.84 M(-46.3%)
Dec 2013
-$53.73 M(-221.7%)
-$15.71 M(+88.2%)
-$53.73 M(+27.2%)
Sep 2013
-
-$8.34 M(-49.9%)
-$42.23 M(-0.1%)
Jun 2013
-
-$16.66 M(+27.9%)
-$42.29 M(-228.1%)
Mar 2013
-
-$13.02 M(+210.2%)
$33.02 M(-25.2%)
Dec 2012
$44.15 M(+341.5%)
-$4.20 M(-50.0%)
$44.15 M(-8.7%)
Sep 2012
-
-$8.40 M(-114.3%)
$48.35 M(-14.8%)
Jun 2012
-
$58.65 M(-3201.5%)
$56.76 M(-3101.5%)
Mar 2012
-
-$1.89 M
-$1.89 M
Dec 2011
$10.00 M
-
-

FAQ

  • What is Epizyme annual cash flow from operations?
  • What is the all time high annual CFO for Epizyme?
  • What is Epizyme annual CFO year-on-year change?
  • What is Epizyme quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Epizyme?
  • What is Epizyme quarterly CFO year-on-year change?
  • What is Epizyme TTM cash flow from operations?
  • What is the all time high TTM CFO for Epizyme?
  • What is Epizyme TTM CFO year-on-year change?

What is Epizyme annual cash flow from operations?

The current annual CFO of EPZM is -$226.85 M

What is the all time high annual CFO for Epizyme?

Epizyme all-time high annual cash flow from operations is $44.15 M

What is Epizyme annual CFO year-on-year change?

Over the past year, EPZM annual cash flow from operations has changed by -$20.52 M (-9.94%)

What is Epizyme quarterly cash flow from operations?

The current quarterly CFO of EPZM is -$54.81 M

What is the all time high quarterly CFO for Epizyme?

Epizyme all-time high quarterly cash flow from operations is $58.65 M

What is Epizyme quarterly CFO year-on-year change?

Over the past year, EPZM quarterly cash flow from operations has changed by +$1.86 M (+3.29%)

What is Epizyme TTM cash flow from operations?

The current TTM CFO of EPZM is -$208.60 M

What is the all time high TTM CFO for Epizyme?

Epizyme all-time high TTM cash flow from operations is $56.76 M

What is Epizyme TTM CFO year-on-year change?

Over the past year, EPZM TTM cash flow from operations has changed by +$19.28 M (+8.46%)